GlassScriptPhysician profile
Denzil Seedial
NPI 1043267909
$15,608.16
in general payments reported to CMS, 2019-2025
38 companies · $8,649 in 2025
The $8,649 reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $563 · 2020: $389 · 2021: $955 · 2022: $736 · 2023: $1,898 · 2024: $2,417 · 2025: $8,649.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,235 · Education: $4,437 · Travel and Lodging: $1,292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,235.38 |
| Education | $4,436.93 |
| Travel and Lodging | $1,292.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,540.84 | 2019-2025 | |
| Glaxosmithkline, LLC. | $1,767.42 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Astrazeneca Pharmaceuticals LP | $1,512.06 | 2020-2025 | Airsupra, Fasenra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $972.41 | 2019-2025 | Ofev, Stiolto Respimat, Jascayd |
| Takeda Pharmaceuticals U.S.A., INC. | $709.57 | 2021-2025 | Glassia |
| United Therapeutics Corporation | $698.12 | 2021-2025 | Tyvaso, Tyvaso |
| Inogen, INC. | $665.72 | 2022-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Actelion Pharmaceuticals US, INC. | $588.40 | 2021-2025 | Uptravi, Opsumit, Opsynvi |
| Grifols USA, LLC | $449.75 | 2019-2025 | Prolastin-C Liquid |
| Ani Pharmaceuticals, INC. | $336.80 | 2024-2025 | Purified Cortrophin Gel |
| Mallinckrodt Hospital Products INC. | $268.22 | 2023-2025 | Acthar |
| Regeneron Healthcare Solutions, INC. | $244.37 | 2019-2025 | Dupixent |
| Mylan Specialty L.P. | $226.11 | 2020-2024 | Yupelri |
| Sanofi-Aventis U.S. LLC | $197.95 | 2022-2023 | |
| Verona Pharma, INC. | $183.41 | 2025 | Ohtuvayre |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $182.32 | 2021-2025 | Inspire |
| Vifor Pharma, INC. | $148.63 | 2024-2025 | Zemaira |
| Amgen INC. | $138.23 | 2022-2025 | Tezspire |
| Insmed, INC. | $130.95 | 2019-2025 | Arikayce, Brinsupri |
| Genzyme Corporation | $90.51 | 2020-2025 | |
| Genentech USA, INC. | $79.90 | 2019 | |
| Novartis Pharmaceuticals Corporation | $48.91 | 2025 | |
| Jazz Pharmaceuticals INC. | $47.77 | 2023-2024 | |
| Harmony Biosciences LLC | $41.67 | 2024 | |
| Abbvie INC. | $41.66 | 2021-2024 | |
| Ethicon INC. | $37.40 | 2020-2021 | |
| Lilly USA, LLC | $34.41 | 2025 | Zepbound |
| Resmed Corp | $29.98 | 2023 | |
| Paratek Pharmaceuticals, INC. | $24.26 | 2024 | Nuzyra |
| Caris Mpi, INC. | $23.22 | 2025 | Mi Cancer Seek |
| Axsome Therapeutics, INC. | $23.07 | 2023 | Sunosi |
| Baxter Healthcare | $21.26 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Covis Pharma Gmbh | $20.51 | 2022 | |
| Tactile Systems Technology INC | $18.36 | 2025 | Flexitouch Plus, Nimbl |
| Shire North American Group INC | $17.83 | 2019 | |
| Apria Healthcare LLC | $17.26 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $16.81 | 2020 | |
| Ambu INC. | $12.09 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denzil Seedial listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.